Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 1
Author(s): Francesca Fallarino
Affiliation:
Export Options
About this article
Cite this article as:
Fallarino Francesca , Meet Our Editorial Board Member, Current Neuropharmacology 2019; 17 (1) . https://dx.doi.org/10.2174/1570159X1701181129110842
DOI https://dx.doi.org/10.2174/1570159X1701181129110842 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
22
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Message from the Editor-in-Chief
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Inflammation as Target for Pharmaceutical Intervention in Cancer (Executive Editors: R.M. Schiffelers and K.E. de Visser)]
Current Pharmaceutical Design Synthesis and Biological Activity of Chiral Dihydropyrazole: Potential Lead for Drug Design
Mini-Reviews in Medicinal Chemistry A Palliative Care Approach to the Advanced Heart Failure Patient
Current Cardiology Reviews Nanocapsulated Ascorbic Acid in Combating Cerebral Ischemia Reperfusion- Induced Oxidative Injury in Rat Brain
Current Alzheimer Research Meet Our Editorial Board Member:
Current Alzheimer Research Therapeutic Use of Molecules that Mimic Pathogen Danger Signals
Endocrine, Metabolic & Immune Disorders - Drug Targets On the Horizon: Promising Investigational Antiretroviral Agents
Current Pharmaceutical Design Therapeutic Strategies for Huntingtons Disease: From the Bench to the Clinic
Current Psychopharmacology Quantifying Risk: The Role of Absolute and Relative Measures in Interpreting Risk of Adverse Reactions from Product Labels of Antipsychotic Medications
Current Drug Safety Synthesis and Some Reactions of 1-aryl-4-acetyl-5-methyl-1,2,3-triazole Derivatives with Anticonvulsant Activity
Mini-Reviews in Medicinal Chemistry Molecular Biology of T-Type Calcium Channels
CNS & Neurological Disorders - Drug Targets The Effect of Liver Cirrhosis on the Regulation and Expression of Drug Metabolizing Enzymes
Current Drug Metabolism Breaking the Chain of Abuse: A Therapeutic Approach for Adolescent Mothers and Their Children
Adolescent Psychiatry Neuropsychological Findings in Obsessive-Compulsive Disorder and its Potential Implications for Treatment
Current Psychiatry Reviews FMRI and Multiple Sclerosis
Current Medical Imaging Pharmacology of Cell Adhesion Molecules of the Nervous System
Current Neuropharmacology Th17 Cells: The Role in Immunity
Current Immunology Reviews (Discontinued) Multigenic Control of Drug Response and Regulatory Decision-Making in Pharmacogenomics: The Need for an Upper-Bound Estimate of Genetic Contributions
Current Pharmacogenomics Does Religiosity Protect Against Cognitive and Behavioral Decline in Alzheimers Dementia?
Current Alzheimer Research